Twitter Facebook LinkedIn YouTube

Preferred Dental Technologies launches 'PDT Wellness', a line of pharmaceutical CBD products for dental offices

Video Platform Video Management Video Solutions Video Player

The company is launching a series of products composed of highest quality, organic, pharmaceutical grade cannabidiol or CBD, which is grown, harvested and manufactured in the US.

Additional Information:

Company: Preferred Dental Technologies
Website: http://www.prefdent.com
Stock Symbol: CSE: PDTI
Date Published: Oct 31, 2018
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

Preferred Dental Technologies, through its wholly owned subsidiary Preferred Dental Implant Corp., is pleased to announce the introduction of “PDT Wellness”, a line of products designed for dental offices.

The company is launching a series of products composed of highest quality, organic, pharmaceutical grade cannabidiol or CBD, which is grown, harvested and manufactured in the US.

PDIC has negotiated a turn-key supply operation including fulfilment center capable of delivering the highest quality pharmaceutical grade CBD to the dental market.

Initial products include soft gel capsules and sublingual tincture delivery methods in a variety of dosage concentrations, with other products expected to follow.

CBD, a non-intoxicating component of hemp and cannabis, has indicated significant supplemental medical benefits.

All “PDT Wellness” products are THC free and will be marketed where legally permitted.

The current opioid epidemic has brought further attention to the potential of CBD supplements, deemed as a safe alternative when addressing pain and other patient symptoms.

This is particularly true in the dental space, where according to many estimates, dentists prescribe 12% of all immediate release opioids in the US, including 50% of all opioids prescribed to adolescents.

Erik Siegmund, President and CEO, stated: “Obviously we are incredibly excited to bring news of
this development to our shareholders. Regardless of the skill of the dental professional, in the
public eye a visit to the dentist is associated with stress and pain. The growing research literature
on CBD supplements as an available option to consider in addressing these symptoms provides
an alternative for precisely these areas making it a natural fit. Additionally, the data on anti-inflammatory qualities of CBD to date is impressive suggesting a strong role in post treatment
healing. PDTI was founded on bringing innovative and practical solutions to the dental industry.
Our original EAS Series of dental implant components, our branching into digital 3D print
solutions and now the ‘PDT Wellness’ line of CBD products all embody this spirit, one which we
plan to continue to grow as the company does.”

The company’s sales team expects to begin introducing CBD based products to dentists and oral surgeons within three weeks.

Preferred Dental has been nominated by Global Health & Pharma as a candidate for a 2018 Technology award, which recognizes companies who are dedicated to creating innovative global healthcare solutions.

The company has been nominated for its EAS Series of dental abutment components.

The shares are trading at $0.05.

For more information about the company, please visit the company’s websites www.prefdent.com, and www.PreferredDentalImplant.com, contact Erik Siegmund, CEO, at 204-691-3722, or email info@prefdent.com.

I’m Samantha Deutscher for Investmentpitch Media